Scarica l'app Stockscreener
50.00
0.79%
0.39
Pre-mercato:
52.75
2.75
+5.50%
Precedente Chiudi:
$49.61
Aprire:
$49.22
Volume 24 ore:
2.42M
Relative Volume:
1.07
Capitalizzazione di mercato:
$5.44B
Reddito:
-
Utile/perdita netta:
$-94.44M
Rapporto P/E:
-48.45
EPS:
-1.032
Flusso di cassa netto:
$-77.99M
1 W Prestazione:
+7.60%
1M Prestazione:
+20.63%
6M Prestazione:
+535.32%
1 anno Prestazione:
+1,325%
Intervallo 1D:
$48.14
$50.37
Intervallo di 1 settimana:
$45.05
$50.89
Portata 52W:
$1.865
$50.89
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Nome
Terns Pharmaceuticals Inc
Settore
Industria
Telefono
650-525-5535 EXT.101
Indirizzo
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
50.00 | 5.44B | 0 | -94.44M | -77.99M | -1.032 |
VRTX
Vertex Pharmaceuticals Inc
|
448.62 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
741.69 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
677.50 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
308.05 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
275.69 | 30.60B | 5.36B | 287.73M | 924.18M | 2.5229 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Iniziato | Leerink Partners | Outperform |
| 2025-11-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | Iniziato | Truist | Buy |
| 2025-09-17 | Iniziato | Barclays | Overweight |
| 2025-09-04 | Ripresa | H.C. Wainwright | Neutral |
| 2025-02-28 | Iniziato | William Blair | Mkt Perform |
| 2024-10-31 | Iniziato | Oppenheimer | Outperform |
| 2023-06-22 | Iniziato | Mizuho | Buy |
| 2023-06-07 | Iniziato | Jefferies | Buy |
| 2023-05-31 | Iniziato | ROTH MKM | Buy |
| 2023-05-08 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-14 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-02-07 | Iniziato | UBS | Buy |
| 2022-09-12 | Iniziato | H.C. Wainwright | Neutral |
| 2021-09-14 | Ripresa | Goldman | Buy |
| 2021-03-02 | Iniziato | Cowen | Outperform |
| 2021-03-02 | Iniziato | Goldman | Buy |
| 2021-03-02 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report - Benzinga
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report - Benzinga
Merck Nears Deal to Buy Terns Pharmaceuticals - Bloomberg.com
SLS Vs. TERN: Which Pharma Stock Has More Upside As Merck Eyes $6B Cancer Bet Ahead Of Keytruda Patent Cliff - Stocktwits
Merck nears $6 bln deal for Terns Pharma, FT reports By Investing.com - Investing.com Canada
Merck (MRK) Nears $6 Billion Acquisition of Terns Pharmaceuticals (TERN) - GuruFocus
Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT (MRK:NYSE) - Seeking Alpha
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - marketscreener.com
According to insiders, merger negotiations between Merck (MRK) and Terns Pharmaceuticals, Inc. (TERN) have entered a critical stage. - Bitget
Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports - marketscreener.com
Acorn Capital Sells $5.2M in Terns Pharma Shares, Remains Top Holding | 2026 UpdateNews and Statistics - IndexBox
Terns Pharmaceuticals (NASDAQ:TERN) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Terns Pharmaceuticals (NASDAQ:TERN) Sets New 12-Month HighShould You Buy? - MarketBeat
TERN Stock Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Aug PreEarnings: What is the target price for Terns Pharmaceuticals Inc stockShare Buyback & Stepwise Trade Execution Plans - baoquankhu1.vn
Terns Pharmaceuticals stock hits all-time high at 48.27 USD By Investing.com - Investing.com Australia
Terns Pharmaceuticals stock hits all-time high at 48.27 USD - Investing.com
How Vestal Point’s Big Bet On TERN-701 At Terns Pharmaceuticals (TERN) Has Changed Its Investment Story - Yahoo Finance
Aug Setups: What is the target price for Terns Pharmaceuticals Inc stockWall Street Watch & Daily Stock Momentum Reports - baoquankhu1.vn
Superstring Capital Reduces Terns Pharmaceuticals Holding in Late 2025News and Statistics - IndexBox
Terns Pharmaceuticals CEO Burroughs sells $681k in stock By Investing.com - Investing.com Canada
Terns Pharmaceuticals CEO Burroughs sells $681k in stock - Investing.com
Amy Burroughs Sells 14,583 Shares of Terns Pharmaceuticals (NASDAQ:TERN) Stock - MarketBeat
Terns Pharmaceuticals CEO Amy L. Burroughs Sells Shares - TradingView
Terns Pharmaceuticals (NASDAQ: TERN) CEO sells exercised shares under plan - Stock Titan
Vestal Point Capital's Major Investment in Terns Pharma | 2026News and Statistics - IndexBox
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally - The Globe and Mail
Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Terns Pharmaceuticals (TERN) Is Up 8.6% After Pipeline Update And Index Inclusion News - simplywall.st
5,700,000 Shares in Terns Pharmaceuticals, Inc. $TERN Acquired by Commodore Capital LP - MarketBeat
Terns Pharmaceuticals Financial Outlook Raises Concerns Amid Market Trends - timothysykes.com
Integral Health Asset Management LLC Grows Stock Holdings in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
4 Biotech Stocks to Watch for Potential Upside in 2026 - The Globe and Mail
Terns Pharmaceuticals’ Valuation Reassessed Amid Latest Developments - StocksToTrade
Terns Pharmaceuticals (NASDAQ:TERN) Trading 4.8% HigherWhat's Next? - MarketBeat
Terns Pharmaceuticals CEO outlines strategy to advance novel leukemia therapy - Traders Union
Terns Pharmaceuticals shares rise as investors focus on recent presentation, index-addition notice, and upcoming earnings - Quiver Quantitative
Terns Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:TERN) - MarketBeat
Terning The Flight to Innovation with Terns Pharma - TD Securities
TERN: TERN-701 shows best-in-disease efficacy and safety in CML, with pivotal trials and launch funded - TradingView
Dynamic Technology Lab Private Ltd Grows Stock Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
TERN: TERN-701 shows superior efficacy and safety in CML, positioning for major market impact - TradingView
DLD Asset Management LP Cuts Stake in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
Will Terns Pharmaceuticals Inc. stock benefit from automation2026 Opening Moves & Safe Entry Momentum Tips - Naître et grandir
Wall Street analysts see a 50.91% upside in Terns Pharmaceuticals (TERN): Can the stock really move this high? - MSN
What is Terns Pharmaceuticals Incs debt to equity ratioWeekly Stock Report & Breakout Confirmation Trade Signals - baoquankhu1.vn
VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals - Stocktwits
TERN Earnings History & Surprises | EPS & Revenue Results | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
TERN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Terns Pharmaceuticals Inc Azioni (TERN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.80%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):